Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosis
Fields of Study & Subjects
Multiple Sclerosis Research Studies
Pregnancy and Medication Impact
Polyomavirus and related diseases
Publication details
- Journal / source
- Multiple Sclerosis and Related Disorders
- Publisher
- Elsevier BV
- Volume
- 109
- Pages
- 107086–107086
- Publication date
- 20 February 2026
- Language
- EN